Table 1

Pseudoaneurysm characteristics and dimensions

Patient Age: sex Procedure Anticoagulation Cavity size (mm) Neck size (mm) Cavity volume (ml) Total thrombin dose (U)
123:FRenal angiogramNone33 × 25 × 39 9 × 332.21000
257:MPTCAA,C13 × 36 × 1116 × 55.2800
358:MPTCA+stent+IABPA,C55 × 23 × 2423 × 430.4500
477:MCoronary angiographyH34 × 25 × 3622 × 230.61000
572:FPTCAA,C48 × 35 × 2015 × 333.6800
661:MPTCAA,H20 × 10 × 1022 × 32.0600
748:MPTCA+stentA,C30 × 20 × 1517 × 29.0600
870:FPTCA+stentA,H,C25 × 50 × 1220 × 515.0600
973:FCoronary angiographyA16 × 16 × 5020 × 312.8500
1059:FIABPA52 × 52 × 32 9 × 486.51000
1158:FPTCA+stentA,C50 × 30 × 2015 × 330.0200
*1258:MCoronary angiographyA,H20 × 20 × 16 5 × 26.4800
1357:MCoronary angiographyA24 × 20 × 1520 × 47.2800
  • Thrombin injection successfully thrombosed all pseudoaneurysms without complication apart from patient 12* in whom arterial thrombus developed immediately after the injection. The thrombus dissolved spontaneously without any vascular intervention.

  • PTCA, percutaneous transluminal coronary angioplasty; IABP, intra-aortic balloon pump; A, aspirin; C, clopidogrel; H, heparin.